// App-Quantinova.ai

: Apixaban in HVAD Patients Non-Compliant to Standard Vitamin-K-Antagonism

Researchers

Presenter

  • S. Schulte-Eistrup

Principal Investigators

  • N. Mayer-Wingert

  • N. Reiss

  • J. Sindermann

  • H. Warnecke

Medical Centers

  • Clinical Research, Schuechtermann Klinik, Bad Rothenfelde, Germany

  • Cardiac Surgery, Schuechtermann Klinik, Bad Rothenfelde, Germany

  • Rehabilitation, Schuechtermann Klinik, Bad Rothenfelde, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Clopidogrel bisulfate

  • apixaban

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved